Proceedings of the 7th International Conference on Neuroscience, Neurology, and Psychiatry Universitas Sumatera Utara (ICONAP 2024)

Mood Stabilizer Induced Steven Johnson Syndrome

A Case Report

Authors
Cindy Chias Arthy1, *, Rini Adriany Lubis1
1Department of Psychiatry, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
*Corresponding author. Email: cindychiasarthy@usu.ac.id
Corresponding Author
Cindy Chias Arthy
Available Online 20 December 2024.
DOI
10.2991/978-94-6463-616-1_6How to use a DOI?
Keywords
Mood stabilizers; Stevens-Johnson Syndrome
Abstract

Mood stabilizers are psychiatric medications used to help control mood swings commonly used to treat people with bipolar disorder. Mood stabilizers consist of several drugs, such as lithium, valproate, carbamazepine, clozapine, olanzapine, quetiapine, aripiprazole, risperidone, and lamotrigine. Some anticonvulsants and memantine show some use in the treatment and prophylaxis of bipolar disorder.

Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute, life-threatening conditions with clinical symptoms of skin erosion and extensive epidermal detachment, usually caused by drug exposure over weeks to months. Although Stevens-Johnson syndrome is a rare disease, it is potentially fatal even among healthy patients. Among anticonvulsants, phenytoin, lamotrigine, and carbamazepine are most frequently associated with SJS/TEN. Very few cases suggest that clozapine, risperidone, ziprasidone, and aripiprazole can cause Stevens-Johnson syndrome. Meanwhile, valproic acid is considered low risk. However, the risk of valproic acid associated with SJS/TEN cannot be underestimated in current clinical practice.

This case report found that several mood stabilizer drugs had the side effects of Stevens-Johnson Syndrome, where clinical symptoms include blistering, swelling and pain in the skin. The patient is known to have been on medication using risperidone and valproic acid in the last three weeks.

Copyright
© 2024 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the 7th International Conference on Neuroscience, Neurology, and Psychiatry Universitas Sumatera Utara (ICONAP 2024)
Series
Advances in Health Sciences Research
Publication Date
20 December 2024
ISBN
978-94-6463-616-1
ISSN
2468-5739
DOI
10.2991/978-94-6463-616-1_6How to use a DOI?
Copyright
© 2024 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Cindy Chias Arthy
AU  - Rini Adriany Lubis
PY  - 2024
DA  - 2024/12/20
TI  - Mood Stabilizer Induced Steven Johnson Syndrome
BT  - Proceedings of the 7th International Conference on Neuroscience, Neurology, and Psychiatry Universitas Sumatera Utara (ICONAP 2024)
PB  - Atlantis Press
SP  - 37
EP  - 41
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-616-1_6
DO  - 10.2991/978-94-6463-616-1_6
ID  - Arthy2024
ER  -